Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

Hashtag, a weekly place for broader context. Saturday Hashtag: #TheBigTobaccoAddictionStrategy originally appeared on ...

Rockville Centre became the first diocese in New York with a confirmed reorganization plan, providing a potential blueprint ...

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic. If the settlement is finalized, it will ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

New York State Attorney General Letitia James said in a statement that the Sackler family will pay up to $6.5 billion, while their privately held company, Purdue Pharma, will pay nearly $900 million.

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

Officials in states and local governments claimed that the opioid crisis was exacerbated by Purdue Pharma’s OxyContin and ...